$60.58
1.93% today
NYSE, Aug 12, 04:15 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Stock price

$59.43
+2.31 4.04% 1M
-24.85 29.49% 6M
-23.28 28.15% YTD
-13.62 18.64% 1Y
-5.88 9.00% 3Y
+5.37 9.93% 5Y
+33.20 126.57% 10Y
+45.93 340.22% 20Y
NYSE, Closing price Mon, Aug 11 2025
+0.78 1.33%

Key metrics

Basic
Market capitalization
$8.0b
Enterprise Value
$7.6b
Net debt
positive
Cash
$461.3m
Shares outstanding
135.4m
Valuation (TTM | estimate)
P/E
44.4 | 18.4
P/S
3.2 | 2.8
EV/Sales
3.0 | 2.6
EV/FCF
14.7
P/B
2.0
Financial Health
Equity Ratio
79.5%
Return on Equity
2.5%
ROCE
10.3%
ROIC
8.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.5b | $2.9b
EBITDA
$565.1m | $839.0m
EBIT
$446.6m | $588.2m
Net Income
$185.6m | $436.9m
Free Cash Flow
$517.6m
Growth (TTM | estimate)
Revenue
32.3% | 15.5%
EBITDA
126.3% | 49.7%
EBIT
157.3% | 33.4%
Net Income
178.5% | 324.2%
Free Cash Flow
241.1%
Margin (TTM | estimate)
Gross
66.9%
EBITDA
22.5% | 28.8%
EBIT
17.8%
Net
7.4% | 15.0%
Free Cash Flow
20.6%
More
EPS
$1.3
FCF per Share
$3.8
Short interest
4.5%
Employees
5k
Rev per Employee
$480.0k
Show more

Is Globus Medical, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Globus Medical, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Globus Medical, Inc. Class A forecast:

14x Buy
67%
7x Hold
33%

Analyst Opinions

21 Analysts have issued a Globus Medical, Inc. Class A forecast:

Buy
67%
Hold
33%

Financial data from Globus Medical, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,511 2,511
32% 32%
100%
- Direct Costs 832 832
16% 16%
33%
1,679 1,679
42% 42%
67%
- Selling and Administrative Expenses 975 975
27% 27%
39%
- Research and Development Expense 139 139
13% 13%
6%
565 565
126% 126%
23%
- Depreciation and Amortization 119 119
56% 56%
5%
EBIT (Operating Income) EBIT 447 447
157% 157%
18%
Net Profit 186 186
179% 179%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Globus Medical, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Globus Medical, Inc. Class A Stock News

Neutral
Seeking Alpha
4 days ago
Globus Medical, Inc. (NYSE:GMED ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Brian J. Kearns - Senior Vice President of Business Development & Investor Relations David C.
Neutral
The Motley Fool
5 days ago
Globus Medical (GMED) Q2 Revenue Up 18%
Neutral
GlobeNewsWire
5 days ago
AUDUBON, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2025.
More Globus Medical, Inc. Class A News

Company Profile

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Head office United States
CEO Daniel Scavilla
Employees 5,300
Founded 2003
Website www.globusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today